sales@angenesci.com
Login | Register
logo
Structures Search
Home Other Building Blocks 2',6'-Pipecoloxylidide

2',6'-Pipecoloxylidide

CAS No.:
15883-20-2
Catalog Number:
AG001QWL
Molecular Formula:
C14H20N2O
Molecular Weight:
232.3214
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
96%
In Stock USA
United States
$13
- +
5g
96%
In Stock USA
United States
$32
- +
25g
96%
In Stock USA
United States
$95
- +
100g
96%
In Stock USA
United States
$285
- +
Product Description
Catalog Number:
AG001QWL
Chemical Name:
2',6'-Pipecoloxylidide
CAS Number:
15883-20-2
Molecular Formula:
C14H20N2O
Molecular Weight:
232.3214
MDL Number:
MFCD01701244
IUPAC Name:
N-(2,6-dimethylphenyl)piperidine-2-carboxamide
InChI:
InChI=1S/C14H20N2O/c1-10-6-5-7-11(2)13(10)16-14(17)12-8-3-4-9-15-12/h5-7,12,15H,3-4,8-9H2,1-2H3,(H,16,17)
InChI Key:
SILRCGDPZGQJOQ-UHFFFAOYSA-N
SMILES:
O=C(C1CCCCN1)Nc1c(C)cccc1C
Properties
Complexity:
257  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
232.158g/mol
Formal Charge:
0
Heavy Atom Count:
17  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
2  
Isotope Atom Count:
0
Molecular Weight:
232.327g/mol
Monoisotopic Mass:
232.158g/mol
Rotatable Bond Count:
2  
Topological Polar Surface Area:
41.1A^2
Undefined Atom Stereocenter Count:
1  
Undefined Bond Stereocenter Count:
0
XLogP3:
2.3  
Literature
Title Journal
Population pharmacokinetic analysis of ropivacaine and its metabolite 2',6'-pipecoloxylidide from pooled data in neonates, infants, and children. British journal of anaesthesia 20110901
Pharmacokinetics of ropivacaine in patients with chronic renal failure. British journal of anaesthesia 20110401
Effects of premedication medicines on the formation of the CYP3A4-dependent metabolite of ropivacaine, 2', 6'-Pipecoloxylidide, on human liver microsomes in vitro. Basic & clinical pharmacology & toxicology 20060201
Nonaromatic hydroxylation of bupivacaine during continuous epidural infusion in man. Journal of biochemical and biophysical methods 20030829
Determination of bupivacaine and metabolites in rat urine using capillary electrophoresis with mass spectrometric detection. Electrophoresis 20030701
Regional transport and metabolism of ropivacaine and its CYP3A4 metabolite PPX in human intestine. The Journal of pharmacy and pharmacology 20030701
Pharmacokinetics of ropivacaine in uremic and nonuremic patients after axillary brachial plexus block. Anesthesia and analgesia 20030201
Effect of ciprofloxacin on the pharmacokinetics of ropivacaine. European journal of clinical pharmacology 20030201
Synthesis and structure-activity relationships of potential anticonvulsants based on 2-piperidinecarboxylic acid and related pharmacophores. European journal of medicinal chemistry 20010301
Acute cardiovascular and central nervous system toxicity of bupivacaine and desbutylbupivacaine in the rat. Acta anaesthesiologica Scandinavica 19920201
Properties